AIHealthcare

AI-in-Healthcare Intelligence Platform

Novelcare

Healthcare AI Clinical-trial matching and patient recruitment Seed

Novelcare, also known as SelectIQ, is a New York City-based healthcare technology company that uses artificial intelligence and electronic-health-record data to help physicians identify medically relevant, locally available clinical trials for their patients and help trial sites recruit participants. Its provider-facing Study Access platform integrates with electronic medical records and is marketed as free for most practices, with paid chart-review workflows for certain studies. The company is active in Y Combinator’s Winter 2023 batch and positions itself around reducing clinical-trial recruitment barriers and expanding patient access to investigational treatments.

Company Details

Website
novel.care
Headquarters
New York City, New York, USA; remote
Founded
2022
Funding
$500K reported seed funding from Y Combinator; other sources report additional backing but do not pr

Subscriber Intelligence

  • • Deal signal alerts for this company
  • • Sentiment & risk scoring
  • • Competitive framework analysis
  • • Regulatory event monitoring
← Back to Company Directory